Search Results - "McCamish, M."

Refine Results
  1. 1
  2. 2

    The Continuum of Comparability Extends to Biosimilarity: How Much Is Enough and What Clinical Data Are Necessary? by McCamish, M, Woollett, G

    Published in Clinical pharmacology and therapeutics (01-04-2013)
    “…Experts debate the clinical evidence standards needed to approve major manufacturing changes for biologics, biosimilars, and interchangeable biosimilars. As…”
    Get full text
    Journal Article
  3. 3

    Molecular “Sameness” Is the Key Guiding Principle for Extrapolation to Multiple Indications by McCamish, M, Woollett, GR

    Published in Clinical pharmacology and therapeutics (01-05-2017)
    “…Much has been made of biosimilars as a new regulatory concept, yet it is clear that misunderstandings are widespread, including the scientific justification…”
    Get full text
    Journal Article
  4. 4

    Toward interchangeable biologics by McCamish, M, Pakulski, J, Sattler, C, Woollett, G

    Published in Clinical pharmacology and therapeutics (01-03-2015)
    “…A biosimilar is designed to match the reference product – to be as close to the reference as the reference is to itself considering batch‐to‐batch variability…”
    Get full text
    Journal Article
  5. 5

    Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency by Farooqi, I. Sadaf, Jebb, Susan A, Langmack, Gill, Lawrence, Elizabeth, Cheetham, Christopher H, Prentice, Andrew M, Hughes, Ieuan A, McCamish, Mark A, O'Rahilly, Stephen

    Published in The New England journal of medicine (16-09-1999)
    “…Severely obese ( ob/ob ) mice are deficient in the adipocyte-derived hormone leptin, which acts on the hypothalamus to control appetite and energy expenditure…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial by Zelissen, P. M. J., Stenlof, K., Lean, M. E. J., Fogteloo, J., Keulen, E. T. P., Wilding, J., Finer, N., Rössner, S., Lawrence, E., Fletcher, C., McCamish, M.

    Published in Diabetes, obesity & metabolism (01-11-2005)
    “…Aim:  The aim of this study was to evaluate the effect on body weight and safety of subcutaneously administered recombinant leptin in obese adults and to…”
    Get full text
    Journal Article
  8. 8

    Predicting early nonelective hospital readmission in nutritionally compromised older adults by Friedmann, JM, Jensen, GL, Smiciklas-Wright, H, McCamish, MA

    Published in The American journal of clinical nutrition (01-06-1997)
    “…This study determined predictors of early nonelective hospital readmission in 92 (49 women and 43 men) nutritionally compromised Medicare patients. Subjects…”
    Get full text
    Journal Article
  9. 9

    The State of the Art in the Development of Biosimilars by McCamish, Mark, Woollett, Gillian

    Published in Clinical pharmacology and therapeutics (01-03-2012)
    “…The development of biologic therapeutics using advanced technology to copy and improve on nature's design of complex peptides, proteins, and glycoproteins has…”
    Get full text
    Journal Article
  10. 10

    Worldwide experience with biosimilar development by McCamish, Mark, Woollett, Gillian

    Published in mAbs (01-03-2011)
    “…Limited access for high-quality biologics due to cost of treatment constitutes an unmet medical need in the United States (US) and other regions of the world…”
    Get full text
    Journal Article
  11. 11

    Intestinal transit and absorption of soy protein in dogs depend on load and degree of protein hydrolysis by Zhao, X T, McCamish, M A, Miller, R H, Wang, L, Lin, H C

    Published in The Journal of nutrition (01-12-1997)
    “…Soy protein, in both intact and hydrolyzed forms, is widely used as the nitrogen source in infant and adult formulas. This protein is also consumed in vast…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Amino Acid Losses During Hemodialysis: Effects of High-Solute Flux and Parenteral Nutrition in Acute Renal Failure by Hynote, Eleanor D., McCamish, Mark A., Depner, Thomas A., Davis, Paul A.

    “…Background: During standard hemodialysis, amino acid losses are substantial, amounting to 6 to 9 g per treatment. When these nutritional supplements are…”
    Get full text
    Journal Article
  17. 17

    Protein absorption depends on load-dependent inhibition of intestinal transit in dogs by Zhao, XT, Miller, RH, McCamish, MA, Wang, L, Lin, HC

    Published in The American journal of clinical nutrition (01-09-1996)
    “…Ileal perfusion of protein slows intestinal transit. Because optimal absorption of nutrients requires adequate time in contact with the mucosa, slowed…”
    Get full text
    Journal Article
  18. 18

    Malnutrition and Clinical Outcomes: The Case for Medical Nutrition Therapy by GALLAGHER ALLRED, CHARLETTE R., COBLE VOSS, ANNE, FINN, SUSAN C., McCAMISH, MARK A.

    “…Malnutrition is not a new or a rare problem. In studies involving more than 1,327 hospitalized adult patients, 40% to 55% were found to be either malnourished…”
    Get full text
    Journal Article
  19. 19

    Recombinant Leptin for Weight Loss in Obese and Lean Adults: A Randomized, Controlled, Dose-Escalation Trial by Heymsfield, Steven B, Greenberg, Andrew S, Fujioka, Ken, Dixon, Russell M, Kushner, Robert, Hunt, Thomas, Lubina, John A, Patane, Janet, Self, Barbara, Hunt, Pam, McCamish, Mark

    “…CONTEXT The protein hormone leptin is important to the homeostatic regulation of body weight. Treatment with exogenous leptin may affect weight loss. OBJECTIVE…”
    Get full text
    Journal Article
  20. 20